Modulating the Optical and Enzymatic Properties of Polydopamine via Valence Engineering of Tungsten Affording NIR‐II Photoacoustic Imaging and Targeted Therapy of Atherosclerosis
Small · 2026
DOI: 10.1002/smll.75061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Yanni Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medic…. Hauptthemen laut MEDLINE: Polymers, Indoles, Photoacoustic Techniques, Atherosclerosis. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangxi Natural Science Foundation, BaGui Youth Top Talent Project of Guangxi.
Abstract (Originalsprache)
Atherosclerosis (AS) is a risk factor for various cardiovascular diseases (CVD), and early diagnosis and plaque removal are challenges in the management of AS and CVD. To address these challenges, we designed a tungsten‑doped polydopamine nanoparticle (W‐PDA NPs). The near‐infrared (NIR) optical absorption and enzymatic properties of W‐PDA were tuned by adjusting the ratio of W 6+ to PDA. It was found that the W‐PDA NPs contain a mixture of W 6+ and W 5+ , which generated large amounts of free electrons, thus conferring both second near‐infrared (NIR‐II) light absorption capability and superoxide dismutase (SOD)‐ and catalase (CAT)‐like activities. Plaque‐targeting was conferred by appending an anti‐osteopontin antibody via coordination between carboxyl moieties of the antibody with W 6+ ions on the W‐PDA surface. The NIR‐II light absorption ability can be utilized for photoacoustic diagnosis of AS, while the SOD‐ and CAT‐like activities facilitate the conversion of superoxide into H 2 O 2 and subsequently O 2 , thereby clearing reactive oxygen species and mitigating inflammation, enabling therapy of AS. Thus, the proposed theranostic agent not only can dynamically report the progression of AS but also can effectively treat AS plaques. This strategy holds broad application prospects in the early and accurate diagnosis and treatment of AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), University Engineerin…
- School of Chemistry and Chemical Engineering, Guangxi Minzu University, Nanning, China.
ORCID-Profile: Fanggui Ye, Shulin Zhao, Liangliang Zhang
Förderung
- National Natural Science Foundation of China
- Guangxi Natural Science Foundation
- BaGui Youth Top Talent Project of Guangxi
- Guangxi Minzu University Talent Introduction and Research Initiation Project
- Natural Science Foundation of Guangxi Province
Zitieren
APA
Luo, Y., Huang, L., Zhao, J., Ma, Y., Tan, X., Ye, F., Zhao, S., Hu, S., & Zhang, L. (2026). Modulating the Optical and Enzymatic Properties of Polydopamine via Valence Engineering of Tungsten Affording NIR‐II Photoacoustic Imaging and Targeted Therapy of Atherosclerosis. Small. https://doi.org/10.1002/smll.75061
Vancouver
Luo Y, Huang L, Zhao J, Ma Y, Tan X, Ye F, et al. Modulating the Optical and Enzymatic Properties of Polydopamine via Valence Engineering of Tungsten Affording NIR‐II Photoacoustic Imaging and Targeted Therapy of Atherosclerosis. Small. 2026. doi:10.1002/smll.75061
BibTeX
@article{Luo2026,
author = {Luo, Yanni and Huang, Lixian and Zhao, Jingjin and Ma, Yuzhen and Tan, Xuecai and Ye, Fanggui and Zhao, Shulin and Hu, Shengqiang and Zhang, Liangliang},
title = {Modulating the Optical and Enzymatic Properties of Polydopamine via Valence Engineering of Tungsten Affording NIR‐II Photoacoustic Imaging and Targeted Therapy of Atherosclerosis},
journal = {Small},
year = {2026},
doi = {10.1002/smll.75061}
}
EUVIMED